253 related articles for article (PubMed ID: 34181166)
1. Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Cançado GGL; Braga MH; Ferraz MLG; Villela-Nogueira CA; Terrabuio DRB; Cançado ELR; Nardelli MJ; Faria LC; de Faria Gomes NM; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; de Lima Pace FH; Pessoa MG; Signorelli IV; Coral GP; Bittencourt PL; Levy C; Couto CA;
Dig Dis Sci; 2022 Jul; 67(7):3305-3312. PubMed ID: 34181166
[TBL] [Abstract][Full Text] [Related]
2. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
[TBL] [Abstract][Full Text] [Related]
3. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
4. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
[TBL] [Abstract][Full Text] [Related]
5. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
6. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.
John BV; Dahman B; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Levy C
Liver Int; 2022 Feb; 42(2):384-393. PubMed ID: 34614294
[TBL] [Abstract][Full Text] [Related]
7. Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study.
Guatibonza-García V; Gaete PV; Pérez-Londoño A; Puerto-Baracaldo DK; Gutiérrez-Romero SA; Mendivil CO; Tapias M
World J Gastroenterol; 2021 Aug; 27(29):4890-4899. PubMed ID: 34447233
[TBL] [Abstract][Full Text] [Related]
8. Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years.
Chang ML; Chen WT; Chan TM; Lin CY; Chang MY; Chen SC; Chien RN
Front Immunol; 2022; 13():869018. PubMed ID: 35663951
[TBL] [Abstract][Full Text] [Related]
9. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti-mitochondrial antibody.
Li CP; Hwang SJ; Chan CY; Lee FY; Huang YS; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):334-40. PubMed ID: 9294912
[TBL] [Abstract][Full Text] [Related]
11. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
[TBL] [Abstract][Full Text] [Related]
14. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up.
Zandanell S; Strasser M; Feldman A; Strebinger G; Aigner G; Niederseer D; Laimer M; Mussnig B; Paulweber B; Datz C; Aigner E
Postgrad Med; 2021 Apr; 133(3):291-298. PubMed ID: 33538618
[No Abstract] [Full Text] [Related]
15. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases.
Goodman ZD; McNally PR; Davis DR; Ishak KG
Dig Dis Sci; 1995 Jun; 40(6):1232-42. PubMed ID: 7781439
[TBL] [Abstract][Full Text] [Related]
17. Role of autoantibodies in the clinical management of primary biliary cholangitis.
Rigopoulou EI; Bogdanos DP
World J Gastroenterol; 2023 Mar; 29(12):1795-1810. PubMed ID: 37032725
[TBL] [Abstract][Full Text] [Related]
18. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis.
Tang L; Zhong R; He X; Wang W; Liu J; Zhu Y; Li Y; Hou J
J Gastroenterol Hepatol; 2017 Mar; 32(3):659-666. PubMed ID: 27529417
[TBL] [Abstract][Full Text] [Related]
20. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
